Increasing debt

Major online travel agencies Expedia (EXPE) and Priceline (PCLN) have developed a duopoly in the online travel market with their aggressive expansion strategy.

For example, Expedia and Priceline have shown interest in China’s (CTRP), with Priceline also increasing its stake. PCLN’s partnership with TripAdvisor’s (TRIP) Instant Booking platform is another effort to outpace EXPE.

Investors Should Pay Attention to Expedia’s Increasing Leverage

Strong cash flows have certainly helped fund many of these acquisitions, although debt has also played a pivotal role. Total debt on Expedia’s balance sheet has increased from ~$1.7 billion at the end of 2014 to ~$3.2 billion at the end of 2015 and ~$3.2 billion at the end of 1Q16.

As a result, EXPE’s leverage ratios too have increased. Its total debt-to-EBITDA ratio increased from ~1.8x at the end of 2014 to 3.5x at the end of 2015 and ~3.5x at the end of 1Q16.

In 3Q15, Expedia went from being net debt negative to net debt positive, meaning that its debt is higher than cash on its balance sheet. Its net debt-to-EBITDA ratio has increased from -0.01x in 2014 to 1.6x at the end of 2015 and 1.2x at the end of 1Q16.

At the end of 1Q16, Expedia’s cash on its balance sheet totaled ~$2.1 billion. EXPE has also generated ~$1.1 billion from cash flow from operations in the first quarter of 2016.

EXPE forms ~1.3% holding of the S&P 500 Pure Growth ETF (RPG).

Why is increasing leverage risky?

Both Expedia and Priceline show no signs of stopping their aggressive expansion spree. Today, EXPE’s debt is at manageable levels, although this is bound to increase as the competition gets tougher.

Also, the US dollar is expected to stay strong for some time given the deteriorating global conditions. This should subdue EXPE’s growth.

High leverage and interest cost reduce its ability to cope with unfavorable conditions, increasing its risk to investors. Investors should pay close attention to Expedia’s increasing leverage.

Latest articles

This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.

Walt Disney’s (DIS) latest movie, Toy Story 4, has reportedly broken records in the opening weekend with $118 million in sales. However, the opening weekend collection was behind analysts’ expectations of at least $150 million in the first weekend.

24 Jun

Will Home Depot’s Upward Momentum to Continue?

WRITTEN BY Rajiv Nanjapla

As of June 21, Home Depot (HD) was trading at $209.39, which implies a rise of 9.7% since the announcement of its first-quarter earnings on May 21. Also, the company was trading at a premium of 32.4% from its 52-week low of $158.09 and a discount of 2.8% from its 52-week high of $215.43.

On June 21, Aurora Cannabis (ACB) made an announcement that indicated that it will move towards higher margin vape products. In addition, the company also believes concentrates and edibles will command higher margins. In anticipation of this development, the company announced the expansion of its facility to capitalize on growth related to these segments.

Shares of Mondelēz International (MDLZ) are scaling new heights thanks to its stellar gains so far this year. Mondelēz stock is up 38.0% on a YTD (year-to-date) basis, and it closed at $55.25—just a shade lower than its 52-week high of $55.71—on June 21.

24 Jun

How Long Will Facebook's Libra Fuel Bitcoin Rally?

WRITTEN BY Mayur Sontakke, CFA, FRM

Ever since the news about Facebook’s (FB) cryptocurrency project broke, Bitcoin has rallied on the hope that Facebook’s entry in the space will help make cryptocurrencies mainstream. Facebook’s cryptocurrency will be called Libra and will be governed by an association with 28 founding members across industries.